Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pafolacianine for Intra-operative Imaging of Ovarian Cancer
NCT03180307Phase 3Completed
- Sponsor
- On Target Laboratories
- Start
- Jan 2018
- Primary completion
- Apr 2020
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of pafolacianine in ovarian cancer, sponsored by On Target Laboratories. Started Jan 2018; status: completed.
02
Drugs
pafolacianine
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT03180307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03180307.